Abstract:Glioblastoma is the most common brain tumor in adults and among the deadliest malignancies per se with a highly invasive phenotype upon presentation. To achieve rapid colonialization throughout the central nervous system, glioblastoma cells have to be equipped with a high resistance to several forms of programmed cell death, such as apoptosis. All this occurs in the absence of any tumor-initiated signature mutations. Using a comprehensive comparative analysis combining expression profiles and functional analysis of normal brain glia cells, primary tumors and tumor-derived organoids with distinct differentiation subtypes we investigated the underlying features associated with the high resistance to cell death-induced by conventional treatment. To break this resistance, we looked into the possibility to add the small molecule inhibitor Venetoclax, that targets the Bcl-2 family, to conventional therapy. The Bcl-2 family are a number of evolutionarily-conserved proteins that share Bcl-2 homology (BH) domains and are most notable for their regulation of apoptosis at the mitochondrion. Interestingly, although stem cell-like cells (SCs) express more pro-apoptotic Bcl-2 family proteins than their differentiated progeny they remain more resistant to apoptosis, suggesting that the Bcl-2 family is not the main mediator of apoptosis resistance. In stark contrast to leukemia cells, inhibition of Bcl-2 alone has no effect on glioblastoma cells, but combining this with either Temozolomide (TMZ), the standard chemotherapeutic option, or serum starvation leads to synergistic effects. These are, however, weak hence we investigated whether compensatory mechanisms are activated. Indeed, in both SCs and DCs we found an upregulation of Mcl-1, a molecule known to compensate for inhibited Bcl-2. However, additionally blocking Mcl-1 with several different small molecule inhibitors did not further sensitize primary Glioblastoma cells. This suggests that while mechanical upregulation of Mcl-1 occurs in Glioblastoma, it is of little functional consequence. The reduced importance of the Bcl-2 family is also reflected in the non-transformed astrocytes which are precursor of glioblastoma. They already display an intrinsic high resistance to apoptotic cell death. Treatment with TMZ and modulators of apoptosis does not significantly affect their viability. Our findings suggest that the Bcl-2 family has a reduced role in mediating the survival of brain cells, at least when compared to haemopoietic cells. While a certain sensitizing effect can be achieved in Glioblastoma cells by combining cellular stressors with inhibitors of the Bcl-2 family, this is unlikely to be a sufficient to overcome therapy resistance. Citation Format: Helene von Bandemer, Felix Seyfried, Anne Fleischmann, Georg Karpel-Massler, Aurelia Peraud, Hannah Strobel, Marcin Lyszkiewicz, Klaus Michael Debatin, Mike Andrew Westhoff. Mechanisms of cell death escape in glioblastoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 2 (Clinical Trials and Late-Breaking Research); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(8_Suppl) nr LB304.

Apoptosis-related gene expression in glioblastoma (LN-18) and medulloblastoma (Daoy) cell lines

Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivo

Identification of Novel Human Glioblastoma-Specific Transcripts by Serial Analysis of Gene Expression Data Mining

Characterization of Prognostic Apoptosis-Related Gene Signature to Evaluate Glioma Immune Microenvironment and Experimental Verification

Autophagy and lysosomal related protein expression patterns in human glioblastoma

The engagement of Ras/Raf/MEK/ERK and PLCγ1/PKC pathways regulated by TrkB receptor in resistance of glioma cells to elimination upon apoptosis induction

Caspase-related Apoptosis Genes in Gliomas by RNA-seq and Bioinformatics Analysis

Abstract LB304: Mechanisms of cell death escape in glioblastoma

Identification of Aloperine As an Anti-Apoptotic Bcl2 Protein Inhibitor in Glioma Cells

Knockdown of Anoikis-Associated Gene OCIAD2 Reduces Proliferation and Migration of Glioblastoma Cell Lines

Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma

Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes

Inhibiting the expression of anti-apoptotic genes BCL2L1 and MCL1, and apoptosis induction in glioblastoma cells by microRNA-342

Knock-Down Of Endogenous Bornavirus-Like Nucleoprotein 1 Inhibits Cell Growth And Induces Apoptosis In Human Oligodendroglia Cells

Silencing LDHA Inhibits Proliferation, Induces Apoptosis and Increases Chemosensitivity to Temozolomide in Glioma Cells

Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma

Two Types of Human Malignant Melanoma Cell Lines Revealed by Expression Patterns of Mitochondrial and Survival-Apoptosis Genes: Implications for Malignant Melanoma Therapy

Effect of down-regulation of X-box binding protein 1 gene expression on viability and apoptosis of glioma cells

The Combination of Baicalin with Knockdown of mir148a Gene Suppresses Cell Viability and Proliferation and Induces the Apoptosis and Autophagy of Human Glioblastoma Multiforme T98G and U87MG Cells

P11.52 Reduced Expression of Proteolipid Protein 2 Increases ER-stress-induced Apoptosis and Autophagy in Glioblastoma

Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas.